vimarsana.com

Latest Breaking News On - Europe policy advisory group - Page 6 : vimarsana.com

The path to recognition: Kosovo s and Serbia s evolving dialogue – European Council on Foreign Relations

The path to recognition: Kosovo s and Serbia s evolving dialogue – European Council on Foreign Relations
ecfr.eu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ecfr.eu Daily Mail and Mail on Sunday newspapers.

In Serbia, COVID vaccine supply outweighs demand amid mistrust

In Serbia, COVID vaccine supply outweighs demand amid mistrust Mersiha Gadzo © A medical worker talks to locals before vaccinating them with the Chinese Sinopharm COVID-19 vaccine. A medical worker talks to locals before vaccinating them with the Chinese Sinopharm COVID-19 vaccine in the village of Leskovik near the city of Nis, Serbia [Marko Djurica/Reuters] With the third-highest rate of inoculations in Europe, Serbia is viewed as something of a Balkan success. But the country has been struggling to find people to vaccinate. Under Serbian President Aleksandar Vucic, Serbia has procured enough vaccines to inoculate its population of seven million, but supply is outpacing demand amid vaccine hesitancy.

Vaccine tourists welcome as Serbians say no thanks to jabs

Vaccine tourists welcome as Serbians say no thanks to jabs Issued on: 04/04/2021 - 06:24 With jabs in abundance, last week Serbia took the highly unusual step of offering foreign citizens the chance to apply to have the shot. Migrants have also been offered the vaccine OLIVER BUNIC AFP 4 min Belgrade (AFP) While most of the world struggles to secure enough Covid-19 vaccines, Serbia faces a different battle how to persuade its citizens to get the life-saving shot. The small Balkan country has so many vaccines available it has even offered jabs to any foreigner who can get themself there, sparking an influx of thousands of vaccine tourists from neighbouring countries.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.